Around the world, asthma, a common lower respiratory tract condition, causes a lot of doctor visits. People of all ages, races, and geographic locations are impacted. Children are more susceptible to diseases because of certain physiological and anatomical characteristics, as well as an underdeveloped immune system. As a result, children have greater rates of incidence and recurrence than adults. According to modern medical knowledge, bronchial asthma is similar to a disorder known as “Tamaka Shvasa” in ancient scriptures. A serious health concern for kids worldwide is bronchial asthma, a chronic airway disease. It can appear at any age and can potentially be lethal in extreme situations. Rajanyadi Churna is one traditional cure that is listed in the Ashtang Hrudya in Balamayapratishedh Adhyaya in uttarsthana, an old Indian literature. Our goal in this study is to investigate Rajanyadi Churna’s therapeutic effectiveness in treating children’s asthma, or Tamak Shwasa.
Patil et al. (Tue,) studied this question.